ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.518,03
-0,44%
S&P 500
5.667,20
0,64%
Dow Jones
40.954,48
1,85%
Euro vs US Dollar
1,09015
0,02%
Bitcoin
64.809,36
-0,06%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC
  6. Arch Therapeutics Inc (QB) (ARTH)

  7. Arch Therapeutics Inc (QB) (ARTH) News

ARTH

Arch Therapeutics (QB) (ARTH)

Arch Therapeutics Inc (QB)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:USOTC:ARTH
DatumZeitQuelleÜberschriftSymbolFirma
21/02/201715h29Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ARTHArch Therapeutics Inc (QB)
16/02/201717h19Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ARTHArch Therapeutics Inc (QB)
09/02/201721h28Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:ARTHArch Therapeutics Inc (QB)
06/02/201717h31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ARTHArch Therapeutics Inc (QB)
06/02/201717h30Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ARTHArch Therapeutics Inc (QB)
06/02/201717h29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ARTHArch Therapeutics Inc (QB)
06/02/201717h27Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ARTHArch Therapeutics Inc (QB)
02/02/201714h23Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ARTHArch Therapeutics Inc (QB)
01/02/201720h27Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ARTHArch Therapeutics Inc (QB)
06/12/201617h01Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:ARTHArch Therapeutics Inc (QB)
05/12/201619h55Edgar (US Regulatory)Annual Report (10-k)USOTC:ARTHArch Therapeutics Inc (QB)
25/11/201613h12Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:ARTHArch Therapeutics Inc (QB)
25/11/201613h11Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:ARTHArch Therapeutics Inc (QB)
25/11/201613h11Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:ARTHArch Therapeutics Inc (QB)
25/11/201612h02Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:ARTHArch Therapeutics Inc (QB)
25/11/201612h02Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:ARTHArch Therapeutics Inc (QB)
25/11/201612h02Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:ARTHArch Therapeutics Inc (QB)
17/11/201619h35Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)USOTC:ARTHArch Therapeutics Inc (QB)
17/11/201619h28Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)USOTC:ARTHArch Therapeutics Inc (QB)
17/11/201619h22Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)USOTC:ARTHArch Therapeutics Inc (QB)
04/11/201612h43Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)USOTC:ARTHArch Therapeutics Inc (QB)
31/10/201622h04Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)USOTC:ARTHArch Therapeutics Inc (QB)
31/10/201622h02Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)USOTC:ARTHArch Therapeutics Inc (QB)
31/10/201621h59Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)USOTC:ARTHArch Therapeutics Inc (QB)
31/10/201613h12Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:ARTHArch Therapeutics Inc (QB)
31/10/201613h10Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:ARTHArch Therapeutics Inc (QB)
31/10/201613h08Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:ARTHArch Therapeutics Inc (QB)
31/10/201613h05Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ARTHArch Therapeutics Inc (QB)
21/10/201612h01Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:ARTHArch Therapeutics Inc (QB)
17/10/201622h04Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)USOTC:ARTHArch Therapeutics Inc (QB)
 Showing the most relevant articles for your search:USOTC:ARTH

Kürzlich von Ihnen besucht

COIN
ETHUSD
Ethereum
NYSE
XOM
Exxon Mobil
TG
TUI1
Tui
NYSE
MRK
Merck
TG
BAYN
Bayer
DBI
MDAX
MDAX
TG
BAS
BASF
NYSE
JPM
JP Morgan Chase
TG
DBK
Deutsche Bank
NASDAQ
QQQ
Invesco QQQ Trust Series 1
CCOM
US500
US 500
FX
EURJPY
Euro vs Yen
AMEX
XLV
Health Care Select Sector
NASDAQ
GOOGL
Alphabet
DBI
SDXP
SDAX
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten